Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Canova Drops
- Development stage
- Preclinical
- Lead developer
- Canova
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Sublingual
01
Overview
Canova Drops is an over-the-counter homeopathic immunomodulator formulation originally developed in Argentina by Dr. Francisco Canova in the 1960s. It is designed to support and enhance the body's natural immune defenses, particularly in patients with compromised immune systems due to conditions such as HIV/AIDS, cancer, rheumatoid arthritis, and chronic infections. The formulation is composed of highly diluted homeopathic ingredients, traditionally including Aconitum napellus, Thuja occidentalis, Bryonia alba, Arsenicum album, and Lachesis muta, among others. It is believed to act primarily by activating macrophages, stimulating the production of reactive oxygen species (ROS) and nitric oxide (NO), and modulating cytokine levels (such as TNF-alpha) to enhance host defense mechanisms without inducing toxicity.
- Brand names
- Canova DropsCanova Immune Support
- Other names
- CanovaCanova MethodMetodo Canova
Beyond the preview
Go deeper on Canova Drops.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Canova Drops.